Australian Vietnam Veterans Mortality and Cancer Incidence Studies

View / Download PDF of Overarching Executive Study (2000 kb)

The following three reports in a series of studies of mortality and cancer incidence in Australian Vietnam veterans were released on September 5th 2006. A fourth report in the series, Dapsone Exposure and Australian Vietnam Service: Moratlity and Cancer Incidence, was released on 26 September 2007.

Cancer Incidence in Australian Vietnam Veterans Study 2005;
The Third Australian Vietnam Veterans Mortality Study 2005; and
Australian National Service Vietnam Veterans: Mortality and Cancer Incidence 2005 and
The Dapsone Exposure and Australian Service in Vietnam: Mortality and Cancer Incidence

The reports were produced by the Department of Veterans’ Affairs with the assistance of the Australian Institute of Health and Welfare.

A fourth report in the series, Dapsone Exposure and Australian Vietnam Service: Mortality and Cancer Incidence, was released on 26 September 2007

The series of studies, commissioned by the Repatriation Commission, was undertaken in response to a recommendation of the 1997 Mortality of Vietnam Veterans: The Veteran Cohort Study, which was to monitor the mortality of Vietnam veterans and repeat the study after 2000.

Each of the four completed reports can stand alone as a complete study. However, the first three volumes should be taken together for a more thorough understanding of the mortality and cancer incidence of this cohort of Australian Vietnam veterans and an Overarching Executive Summary has been produced to assist in understanding . The fourth volume investigates a specific aspect of Vietnam service, that is, the exposure to an anti-malarial drug, Dapsone.

• View the Cancer Incidence in Australian Vietnam Veterans Study 2005
• View The Third Australian Vietnam Veterans Mortality Study 2005
• View The Australian National Service Vietnam Veterans: Mortality and Cancer Incidence 2005
• View The Dapsone Exposure and Australian Service in Vietnam: Mortality and Cancer Incidence